De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.

Autor: Hornak T; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Mayer J; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Cicatkova P; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Semerad L; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Kvetkova A; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Klamova H; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Faber E; Dpt. of Hemato-oncology, University Hospital Olomouc and Palacky University, Olomouc, Czech Republic., Belohlavkova P; 4th Dpt. of Internal Medicine and Hematology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic., Karas M; Dpt. of Hemato-oncology, University Hospital Pilsen and Charles University, Pilsen, Czech Republic., Stejskal L; Dpt. of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Dpt. of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Cmunt E; 1st. Internal Dpt, General University Hospital Prague, Prague, Czech Republic., Cerna O; Dpt. of Hematology, University Hospital Kralovske Vinohrady and Charles University, Prague, Czech Republic., Srbova D; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Zizkova H; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Vrablova L; Dpt. of Hemato-oncology, University Hospital Olomouc and Palacky University, Olomouc, Czech Republic., Skoumalova I; Dpt. of Hemato-oncology, University Hospital Olomouc and Palacky University, Olomouc, Czech Republic., Voglova J; 4th Dpt. of Internal Medicine and Hematology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic., Jurkova T; Institute of Biostatistics and Analyses, Brno, Czech Republic., Chrapava M; Institute of Biostatistics and Analyses, Brno, Czech Republic., Jurcek T; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Jeziskova I; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Jarosova M; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Machova Polakova K; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Papajik T; Dpt. of Hemato-oncology, University Hospital Olomouc and Palacky University, Olomouc, Czech Republic., Zak P; 4th Dpt. of Internal Medicine and Hematology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic., Jindra P; Dpt. of Hemato-oncology, University Hospital Pilsen and Charles University, Pilsen, Czech Republic., Zackova D; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Apr; Vol. 99 (4), pp. 763-766. Date of Electronic Publication: 2024 Feb 05.

The Use of RAPD and AFLP Markers for Characterisation of Winter Barley Genotypes for Breeding to Fusarium Head Blight Resistance

Autor: Nesvadba, Z., Vyhnanek, T., Jeziskova, I., Tvaruzek, L., Spunar, J., Pouch, M.

Publikováno v: Cereal Research Communications, 2008 Mar 01. 36(1), 1-10.

Externí odkaz: https://www.jstor.org/stable/23789865

Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.

Autor: Durinikova A; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Folta A; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Pardy F; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Svaton J; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Drncova M; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Weinbergerova B; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Cetkovsky P; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Racil Z; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Jindra P; Department of Hematology and Oncology, University Hospital Pilsen, Pilsen, Czech Republic., Szotkowski T; Department of Hemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic., Zak P; Department of Internal Medicine - Department of Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Mayer J; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Jeziskova I; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3237-3240. Date of Electronic Publication: 2022 Sep 01.

Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.

Autor: Herudkova Z; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Culen M; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Folta A; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Jeziskova I; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Cerna J; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Loja T; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Tom N; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Smejkal J; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Semerad L; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Dvorakova D; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Mayer J; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Racil Z; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.

Publikováno v: British journal of haematology [Br J Haematol] 2020 Aug; Vol. 190 (4), pp. 562-572. Date of Electronic Publication: 2019 Dec 10.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.